On the biological activity of anti-ICAM-1 oligonucleotides complexed to non-viral carriers.
- 16 April 2004
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 96 (1) , 207-219
- https://doi.org/10.1016/j.jconrel.2003.12.028
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Polyethylenimine but Not Cationic Lipid Improves Antisense Activity of 3′-Capped Phosphodiester OligonucleotidesAntisense and Nucleic Acid Drug Development, 1999
- Delivery of Antisense Oligonucleotides and Plasmid DNA with Various Carrier AgentsAntisense and Nucleic Acid Drug Development, 1999
- Cationic Lipids Employed for Antisense Oligodeoxynucleotide Transport May Inhibit Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells: A Word of CautionAntisense and Nucleic Acid Drug Development, 1999
- Self-Assembly of Polyamine−Poly(ethylene glycol) Copolymers with Phosphorothioate OligonucleotidesBioconjugate Chemistry, 1998
- Active nuclear import of single-stranded oligonucleotides and their complexes with non-karyophilic macromoleculesBiology of the Cell, 1998
- Up-Regulation of Luciferase Gene Expression with Antisense Oligonucleotides: Implications and Applications in Functional Assay DevelopmentBiochemistry, 1998
- β2 Integrin/ICAM Expression in Crohn's DiseaseClinical Immunology and Immunopathology, 1998
- Identification and Partial Purification of Human Double Strand RNase ActivityJournal of Biological Chemistry, 1998
- Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet?Journal of Controlled Release, 1996
- Antisense oligonucleotide therapeutics: drug delivery and targetingAdvanced Drug Delivery Reviews, 1996